Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
J Immunol. 2010 Nov 15;185(10):6234-43. doi: 10.4049/jimmunol.1000198. Epub 2010 Oct 8.
To activate naive T cells convincingly using Mycobacterium bovis bacillus Calmette-Guérin (BCG), recombinant BCG (BCG-D70M) that was deficient in urease, expressed with gene encoding the fusion of BCG-derived heat shock protein (HSP) 70 and Mycobacterium leprae-derived major membrane protein (MMP)-II, one of the immunodominant Ags of M. leprae, was newly constructed. BCG-D70M was more potent in activation of both CD4(+) and CD8(+) subsets of naive T cells than recombinant BCGs including urease-deficient BCG and BCG-70M secreting HSP70-MMP-II fusion protein. BCG-D70M efficiently activated dendritic cells (DCs) to induce cytokine production and phenotypic changes and activated CD4(+) T cells even when macrophages were used as APCs. The activation of both subsets of T cells was MHC and CD86 dependent. Pretreatment of DCs with chloroquine inhibited both surface expression of MMP-II on DCs and the activation of T cells by BCG-D70M-infected APCs. The naive CD8(+) T cell activation was inhibited by treatment of DCs with brefeldin A and lactacystin so that the T cell was activated by TAP- and proteosome-dependent cytosolic cross-priming pathway. From naive CD8(+) T cells, effector T cells producing perforin and memory T cells having migration markers were produced by BCG-D70M stimulation. BCG-D70M primary infection in C57BL/6 mice produced T cells responsive to in vitro secondary stimulation with MMP-II and HSP70 and more efficiently inhibited the multiplication of subsequently challenged M. leprae than vector control BCG. These results indicate that the triple combination of HSP70, MMP-II, and urease depletion may provide a useful tool for inducing better activation of naive T cells.
为了使用牛分枝杆菌卡介苗(BCG)令人信服地激活幼稚 T 细胞,构建了一种新的重组 BCG(BCG-D70M),它缺乏脲酶,表达的融合基因编码来自 BCG 的热休克蛋白(HSP)70 和麻风分枝杆菌主要膜蛋白(MMP)-II,这是麻风分枝杆菌的免疫优势抗原之一。与包括缺乏脲酶的 BCG 和分泌 HSP70-MMP-II 融合蛋白的 BCG-70M 在内的重组 BCG 相比,BCG-D70M 更能有效激活幼稚 CD4(+)和 CD8(+)T 细胞亚群。BCG-D70M 能有效激活树突状细胞(DC),诱导细胞因子产生和表型变化,并激活 CD4(+)T 细胞,即使使用巨噬细胞作为 APC 也是如此。两种 T 细胞亚群的激活都依赖于 MHC 和 CD86。用氯喹预处理 DC 可抑制 MMP-II 在 DC 表面的表达以及 BCG-D70M 感染的 APC 对 T 细胞的激活。用布雷菲德菌素 A 和乳胞素处理 DC 可抑制幼稚 CD8(+)T 细胞的激活,因此 T 细胞通过 TAP 和蛋白酶体依赖的胞质交叉呈递途径被激活。从幼稚 CD8(+)T 细胞中,效应 T 细胞产生穿孔素和具有迁移标志物的记忆 T 细胞由 BCG-D70M 刺激产生。BCG-D70M 在 C57BL/6 小鼠中的初次感染产生了对 MMP-II 和 HSP70 的体外二次刺激有反应的 T 细胞,并且比载体对照 BCG 更有效地抑制随后挑战的麻风分枝杆菌的增殖。这些结果表明,HSP70、MMP-II 和脲酶缺失的三联组合可能为诱导幼稚 T 细胞更好地激活提供有用的工具。